Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Primary dysmenorrhea (PD) is a common, disregarded, underdiagnosed, and inadequately treated complaint of both young and adult females. It is characterized by painful cramps in the lower abdomen, which start shortly be-fore or at the onset of menses and which could last for 3 days. In particular, PD negatively impacts the quality of life (QOL) of young females and is the main reason behind their absenteeism from school or work. It is suggested that increased intrauterine secretion of prostaglandins F2α and E2 are responsible for the pelvic pain associated with this disorder. Its associated symptoms are physical and/or psychological. Its physical symptoms include headache, lethargy, sleep disturbances, tender breasts, various body pains, disturbed appetite, nausea, vomiting, constipation or diarrhea, and increased urination, whereas its psychological symptoms include mood disturbances, such as anxiety, depression, and irritability. While its diagnosis is based on patients’ history, symptoms, and physical exam-ination, its treatment aims to improve the QOL through the administration of nonsteroidal anti-inflammatory drugs, hormonal contraceptives, and/or the use of non-pharmacological aids (e.g., topical heat application and ex-ercise). Patients must be monitored to measure their response to treatment, assess their adherence, observe poten-tial side effects, and perform further investigations, if needed.
Abstract
Primary dysmenorrhea (PD) is a common, disregarded, underdiagnosed, and inadequately treated complaint of both young and adult females. It is characterized by painful cramps in the lower abdomen, which start shortly be-fore or at the onset of menses and which could last for 3 days. In particular, PD negatively impacts the quality of life (QOL) of young females and is the main reason behind their absenteeism from school or work. It is suggested that increased intrauterine secretion of prostaglandins F2α and E2 are responsible for the pelvic pain associated with this disorder. Its associated symptoms are physical and/or psychological. Its physical symptoms include headache, lethargy, sleep disturbances, tender breasts, various body pains, disturbed appetite, nausea, vomiting, constipation or diarrhea, and increased urination, whereas its psychological symptoms include mood disturbances, such as anxiety, depression, and irritability. While its diagnosis is based on patients’ history, symptoms, and physical exam-ination, its treatment aims to improve the QOL through the administration of nonsteroidal anti-inflammatory drugs, hormonal contraceptives, and/or the use of non-pharmacological aids (e.g., topical heat application and ex-ercise). Patients must be monitored to measure their response to treatment, assess their adherence, observe poten-tial side effects, and perform further investigations, if needed.
참고문헌 (64)
- Iacovides S, "What we know about primary dysmenorrhea today : a critical review", Hum Reprod Update, 21, pp.762~778 (2015)
- Chen CX, "Reasons women do not seek health care for dysmenorrhea", J Clin Nurs, 27, pp.e301~e308 (2018)
- Proctor M, "Diagnosis and management of dysmenorrhoea", BMJ, 332, pp.1134~1138 (2006)
- Sharghi M, "An update and systematic review on the treatment of primary dysmenorrhea", JBRA Assist Reprod, 23, pp.51~57 (2019)
- Proctor ML, "Dysmenorrhoea", BMJ Clin Evid, 2007, pp.0813~ (2007)
- Chen L, "Primary dysmenorrhea and self-care strategies among Chinese college girls : a cross-sectional study", BMJ Open, 9, pp.e026813~ (2019)
- Rafique N, "Prevalence of menstrual problems and their association with psychological stress in young female students studying health sciences", Saudi Med J, 39, pp.67~73 (2018)
- Morrow C, "Dysmenorrhea", Prim Care, 36, pp.19~32 (2009)
- Parra-Fernandez ML, "Management of primary dysmenorrhea among university students in the south of Spain and family influence", Int J Environ Res Public Health, 17, pp.5570~ (2020)
- Mendiratta V, "Comprehensive gynecology", pp.815~828 (2017), Elsevier Inc
- Latthe P, "Factors predisposing women to chronic pelvic pain : systematic review", BMJ, 332, pp.749~755 (2006)
- Osayande AS, "Diagnosis and initial management of dysmenorrhea", Am Fam Physician, 89, pp.341~346 (2014)
- Burnett M, "No. 345: primary dysmenorrhea consensus guideline", J Obstet Gynaecol Can, 39, pp.585~595 (2017)
- Abreu-Sanchez A, "Type of dysmenorrhea, menstrual characteristics and symptoms in nursing students in southern Spain", Healthcare(Basel), 8, pp.302~ (2020)
- Bernardi M, "Dysmenorrhea and related disorders", F1000Res, 6, pp.1645~ (2017)
- Ju H, "The prevalence and risk factors of dysmenorrhea", Epidemiol Rev, 36, pp.104~113 (2014)
- Kuphal GJ, "Integrative medicine", pp.569~577 (2018), Elsevier Inc
- Borgelt LM, "Applied therapeutics: the clinical use of drugs", pp.1005~1027 (2018), Wolter Kluwer
- Unsal A, "Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students", Ups J Med Sci, 115, pp.138~145 (2010)
- Abu Helwa HA, "Prevalence of dysmenorrhea and predictors of its pain intensity among Palestinian female university students", BMC Womens Health, 18, pp.18~ (2018)
- Wong CL, "Health-related quality of life among Chinese adolescent girls with dysmenorrhoea", Reprod Health, 15, pp.80~ (2018)
- Barcikowska Z, "Inflammatory markers in dysmenorrhea and therapeutic options", Int J Environ Res Public Health, 17, pp.1191~ (2020)
- Chan WY, "Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects", Prostaglandins, 15, pp.365~375 (1978)
- Dawood MY, "Primary dysmenorrhea : advances in pathogenesis and management", Obstet Gynecol, 108, pp.428~441 (2006)
- "Dysmenorrhea: practice essentials, background, pathophysiology" (2019)[URL]
- Agarwal AK, "A study of dysmenorrhea during menstruation in adolescent girls", Indian J Community Med, 35, pp.159~164 (2010)
- Matthewman G, "Physical activity for primary dysmenorrhea : a systematic review and meta-analysis of randomized controlled trials", Am J Obstet Gynecol, 219, pp.255.e1~255.e20 (2018)
- Jones AV, "Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus", Pain, 157, pp.2571~2581 (2016)
- Kho KA, "Diagnosis and management of primary dysmenorrhea", JAMA, 323, pp.268~269 (2020)
- "ACOG committee opinion no. 760: dysmenorrhea and endometriosis in the adolescent", Obstet Gynecol, 132, pp.e249~e258 (2018)
- Brandt A, "Hyperinsulinism hyperammonaemia(HI", HA)syndrome due to GLUD1 mutation : phenotypic variations ranging from late presentation to spontaneous resolution, 2020, pp.33, 675~679
- Katz JN, "Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities", Osteoarthritis Cartilage, 24, pp.409~418 (2016)
- Marjoribanks J, "Nonsteroidal antiinflammatory drugs for dysmenorrhoea", Cochrane Database Syst Rev, 2015, pp.CD001751~ (2015)
- Oladosu FA, "Nonsteroidal antiinflammatory drug resistance in dysmenorrhea : epidemiology, causes, and treatment", Am J Obstet Gynecol, 218, pp.390~400 (2018)
- Lazzaroni M, "Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations", Aliment Pharmacol Ther, 20(Suppl 2), pp.48~58 (2004)
- Duggan KC, "Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen", J Biol Chem, 285, pp.34950~34959 (2010)
- Harel Z, "Dysmenorrhea in adolescents and young adults : an update on pharmacological treatments and management strategies", Expert Opin Pharmacother, 13, pp.2157~2170 (2012)
- Ryan SA, "The treatment of dysmenorrhea", Pediatr Clin North Am, 64, pp.331~342 (2017)
- Wong CL, "Oral contraceptive pill for primary dysmenorrhoea", Cochrane Database Syst Rev, 2009, pp.CD002120~ (2009)
- Curtis KM, "U.S. medical eligibility criteria for contraceptive use, 2016", MMWR Recomm Rep, 65, pp.1~103 (2016)
- "Medical eligibility criteria for contraceptive use" (2015)[URL]
- Lindh I, "The effect of combined oral contraceptives and age on dysmenorrhoea : an epidemiological study", Hum Reprod, 27, pp.676~682 (2012)
- Maguire K, "The state of hormonal contraception today : established and emerging noncontraceptive health benefits", Am J Obstet Gynecol, 205(4 Suppl), pp.S4~S8 (2011)
- Lefebvre G, "Primary dysmenorrhea consensus guideline", J Obstet Gynaecol Can, 27, pp.1117~1146 (2005)
- Hinz B, "Paracetamol and cyclooxygenase inhibition : is there a cause for concern?", Ann Rheum Dis, 71, pp.20~25 (2012)
- Dawood MY, "Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2alpha in a randomized, double-blind, crossover treatment with placebo, acetaminophen, and ibuprofen in primary dysmenorrhea", Am J Obstet Gynecol, 196, pp.35.e1~35.e5 (2007)
- Chen CX, "Perceived ineffectiveness of pharmacological treatments for dysmenorrhea", J Womens Health(Larchmt), 30, pp.1334~1343 (2021)
- Armour M, "Self-care strategies and sources of knowledge on menstruation in 12, 526 young women with dysmenorrhea : a systematic review and meta-analysis", PLoS One, 14, pp.e0220103~ (2019)
- Armour M, "The effectiveness of selfcare and lifestyle interventions in primary dysmenorrhea : a systematic review and meta-analysis", BMC Complement Altern Med, 19, pp.22~ (2019)
- Nie W, "Efficacy and safety of overthe-counter analgesics for primary dysmenorrhea: a network metaanalysis", Medicine (Baltimore), 99, pp.e19881~ (2020)
- Daley AJ, "Exercise and primary dysmenorrhoea : a comprehensive and critical review of the literature", Sports Med, 38, pp.659~670 (2008)
- Jo J, "Heat therapy for primary dysmenorrhea : a systematic review and meta-analysis of its effects on pain relief and quality of life", Sci Rep, 8, pp.16252~ (2018)
- Subasinghe AK, "Prevalence and severity of dysmenorrhoea, and management options reported by young Australian women", Aust Fam Physician, 45, pp.829~834 (2016)
- Bai HY, "Effect of transcutaneous electrical nerve stimulation therapy for the treatment of primary dysmenorrheal", Medicine(Baltimore), 96, pp.e7959~ (2017)
- 정재광, "Basic Understanding of Transcutaneous Electrical Nerve Stimulation", Journal of Oral Medicine and Pain, 41(4), pp.145~154 (2016), 대한안면통증∙구강내과학회[DOI]
- Peng WW, "Neurobiological mechanisms of TENS-induced analgesia", Neuroimage, 195, pp.396~408 (2019)
- Johnson M, "Transcutaneous electrical nerve stimulation : mechanisms, clinical application and evidence", Rev Pain, 1, pp.7~11 (2007)
- Wang SF, "Effect of transcutaneous electrical nerve stimulation on primary dysmenorrhea", Neuromodulation, 12, pp.302~309 (2009)
- Igwea SE, "TENS and heat therapy for pain relief and quality of life improvement in individuals with primary dysmenorrhea : a systematic review", Complement Ther Clin Pract, 24, pp.86~91 (2016)
- Johnson MI, "Transcutaneous electrical nerve stimulation for acute pain", Cochrane Database Syst Rev, 2015, pp.CD006142~ (2015)
- Gibson W, "Transcutaneous electrical nerve stimulation(TENS)for chronic pain : an overview of Cochrane Reviews", Cochrane Database Syst Rev, 4, pp.CD011890~ (2019)
- Proctor ML, "Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea", Cochrane Database Syst Rev, (4), pp.CD001896~ (2005)
- Berner E, "Pain reduction after total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy among women with dysmenorrhoea : a randomised controlled trial", BJOG, 122, pp.1102~1111 (2015)
- Bourdel N, "Systematic review of endometriosis pain assessment : how to choose a scale?", Hum Reprod Update, 21, pp.136~152 (2015)